Vital patent for AlzeCure Alzheimer’s drug
ACD856 is the leading candidate therapy on the company’s NeuroRestore platform
Read More
Tag: patent
Touchlight signs patent agreement with Pfizer
Deal involves the manufacturing of mRNA-based vaccines, therapeutics and gene therapies
Read More
Evotenix receives patent for gene synthesis method
Vital patent for Evotenix is anticipated to enable a new generation of DNA synthesis platforms
Read More
US supports waiving IP for COVID vaccines
MSF has applauded the move, but the IFPMA said the decision is “disappointing”
Read More
US court rules in favour of AZ in Symbicort patent litigation
Court decision rules against Mylan Pharmaceuticals and Kindeva Drug Delivery
Read More
NHS saves more than £700m on medicines costs
A huge part of the saving was made up by AbbVie’s Humira losing its patent.
Read More
BIA gets green light to intervene in Actavis/ICOS patent case
The Supreme Court has given its consent to the UK’s BioIndustry Association (BIA) to intervene in a case that the latter says “could have far-reaching impacts on the life sciences sector”.
Read More
Pfizer loses second medical use patent case
Pfizer says it is disappointed with a UK Court of Appeal ruling backing an earlier judgement that its patent protecting pregabalin for pain has not been infringed by Actavis.
Read More
University sues Gilead for patent infringement
The University of Minnesota has filed a lawsuit against Gilead Sciences claiming that the drugmaker’s hepatitis C drugs violate its intellectual property.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
